David Evans
Analyst · Gabelli Research. Your line is now open
Thanks, Lynne. Revenue within our core Cardlytics Direct business was $34.4 million, representing 14% year-over-year growth over the third quarter of 2017. Our U.S. Direct business was up 20% year-over-year in Q3, partially offset by a temporary decline in our UK business. Revenue for our direct business fell short of our expectations in the third quarter, primarily due to a few anticipated advertisements that were not in the channel. Total revenue for the third quarter was $34.6 million, representing an increase of 10% over the third quarter of 2017. Revenue from other platform solutions was approximately $0.2 million compared to $1.2 million in the third quarter of 2017. Our third quarter core Cardlytics Direct revenue growth reflects growth from new marketers, improved engagement enhancements with our banks and year-over-year growth in MAUs. MAUs grew 7% over the third quarter of 2017 from 55.4 million to 59.3 million. Consistent with our commentary on our last call, we expect significant MAU growth in the first half of 2019 continuing into 2020 as we prepare to launch Wells Fargo in addition to Chase. Our third quarter 2018 ARPU was $0.58, up 6% from $0.55 in the third quarter of 2017, reflecting continued momentum with our marketer base. Total adjusted contribution profit was $17 million in the third quarter, up from $16.2 million in the prior quarter and down slightly from $17.2 million in the third quarter of 2017. To be fair, during the third quarter of 2017, we reversed a non-cash guarantee shortfall growth of $3 million. And during the third quarter of 2018, we recognized a positive impact and true-up from the Lloyds' revenue share contract change of $800,000. Excluding these benefits, total adjusted contribution profit represents 14% year-over-year growth and Cardlytics Direct adjusted contribution profit represents 17% period-over-period growth, when excluding the benefits I just discussed. Adjusted EBITDA was a $1.7 million loss in the third quarter of 2018 compared to a positive $71,000 in the third quarter of 2017. Our third quarter adjusted EBITDA was above our expectations and benefited from the $800,000 true-up from our renegotiated Lloyds contract mentioned previously, timing related to new hires and coming in under budget on certain Wells and Chase related investments. On an apples-to-apples basis, when excluding the Lloyds' contract benefit and guarantee shortfall adjustment in Q3 2017, our adjusted EBITDA would have improved by 18%. We entered the quarter with $67.8 million on cash compared to $70.5 million at the end of Q2 2018. Our cash balance includes $20 million of restricted cash. We ended the quarter with $3.1 million in availability on our AR facility. Now turning to our guidance, we are updating our full-year 2018 revenue guidance of $146 million to $148 million. We expect our 2018 adjusted EBITDA loss to be between minus $9.4 million and minus $8.4 million. This is over $3 million improvement from the midpoint of our previous full year adjusted EBITDA guidance, as we efficiently managed budgets and accrue some of the Q3 savings that flow through the remainder of the year. As an aside, we are no longer anticipating any accruals in 2018 for any FI share commitment shortfall. We currently expect this to take place sometime in 2019, and in which case, we would anticipate a shortfall in the 12 months thereafter. In the fourth quarter, we currently expect revenue to be between $43 million and $45 million. It is worth noting that we have added a bit of room for variability in Q4 top line revenues, as Chase comes online. Given the timing of the late Q4 launch relative to marketing budgeting cycles, we expect that the Chase launch will impact Q4 MAUs. However, we don't expect to see material financial impact until early next year as marketers expand budgets for our increased scale. While we have gone to great lengths to analyze and estimate Chase's impact on revenues, we ultimately will not know with precision until they're up and running. We expect adjusted EBITDA loss for the fourth quarter to be between minus $2.5 million to minus $1.5 million. For our bottom line exceeded expectations for 2018, revenues not expected to meet our prior expectations. However, we remain very excited about the 2019 opportunity for Cardlytics, especially with the launch of the first of two new national banks. With that, I'll hand it back to Scott for his closing remarks, before we open the call to your questions. Scott?